Optos, one of the world’s leading manufacturers of retinal imaging technology and part of Nikon Corporation, has launched its latest ultra-widefield device to the European ophthalmic market.

Monaco is set to revolutionise the way eyecare professionals examine the eye and is the only ultra-widefield retinal imaging system with integrated Optical Coherence Tomography. It produces a 200° single-capture optomap image in less than ½ second but is unique as it also provides cross-sectional Optical Coherence Tomography views of retinal structures.

The device enables rapid multi-modality capture featuring colour, autofluorescence and Optical Coherence Tomography scans for both eyes in just 90 seconds.

Both the optomap images and Optical Coherence Tomography scans are correlated to facilitate a more in-depth pathology exam. This means optometrists can perform a comprehensive examination on patients knowing ocular disease and potential issues are tested for.

The 2-in-1 compact desk-top retinal imaging device also benefits optometrists as the device saves space in the practice compared to multi-devices and provides increased clinical information, improving overall practice efficiency.

Gareth Steer, Vice President Sales, Europe at Optos, said:
“Monaco is a unique imaging system, that can capture ultra-widefield red/green and autofluorescence images, as well as having Optical Coherence Tomography capability. The device is very comfortable for patients and can capture all three modalities in under two minutes.

“Monaco gives both optometrists and patients great peace of mind, knowing that pathologies can be identified, even in the periphery, and that potentially sight-threatening conditions can be discovered and treated at an early stage.

“We’re bringing a device to the market that further enhances the detection of retinal issues and continues to improve practice efficiency. Our goal is to provide outstanding technology and customer service to the practices that we work with, to help them to provide the best possible care for their patients”.

Monaco was launched in the US in May this year where eyecare professionals have been reaping the benefits of the new device.

Optometrist Simon Browning has worked with Optos equipment for over 20 years and recently started using the new Monaco device.


Simon said:
“Monaco is set to give us greater analysis of retinal health and increased diagnostic capability. Having two systems in one instrument has greatly sped up the flow through the clinic session. What’s even more important is the diagnostic image capabilities of the software.

“The OptosAdvance review software combines optomap and Optical Coherence Tomography retinal images on one screen. The ease of moving between the two modalities makes this a brilliant tool to use in the consulting room.

“With both practices and customers living in a time-poor era, it’s essential for devices to work as efficiently as possible, and with excellence. For eyecare professionals looking for one device to do it all, I’d highly recommend Monaco. I’m confident it will save the eyesight of many people and allow clinics to work more effectively.”

Optos has been based in Dunfermline, Scotland since it was founded 26 years ago by Douglas Anderson. Douglas developed the ground-breaking optomap retinal imaging technology following his five-year old son losing his eye sight in one eye due to a retinal detachment.

The company, which is now owned by Nikon, has since sold over 13,000 optomap devices worldwide and has offices across Europe, North America, Asia and Australia.

For further information about the new Monaco device, please visit

 Monaco Patient 3 600x400